RNA-based Biopharmaceuticals Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 RNA-based Biopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA-based Biopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA-based Biopharmaceuticals Overall Market Size
2.1 Global RNA-based Biopharmaceuticals Market Size: 2021 VS 2027
2.2 Global RNA-based Biopharmaceuticals Revenue, Prospects & Forecasts: 2016-2027
2.3 Global RNA-based Biopharmaceuticals Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top RNA-based Biopharmaceuticals Players in Global Market
3.2 Top Global RNA-based Biopharmaceuticals Companies Ranked by Revenue
3.3 Global RNA-based Biopharmaceuticals Revenue by Companies
3.4 Global RNA-based Biopharmaceuticals Sales by Companies
3.5 Global RNA-based Biopharmaceuticals Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 RNA-based Biopharmaceuticals Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers RNA-based Biopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 RNA-based Biopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 RNA-based Biopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 RNA-based Biopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA-based Biopharmaceuticals Market Size Markets, 2021 & 2027
4.1.2 Therapeutics
4.1.3 Vaccines
4.2 By Type - Global RNA-based Biopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global RNA-based Biopharmaceuticals Revenue, 2016-2021
4.2.2 By Type - Global RNA-based Biopharmaceuticals Revenue, 2022-2027
4.2.3 By Type - Global RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
4.3 By Type - Global RNA-based Biopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global RNA-based Biopharmaceuticals Sales, 2016-2021
4.3.2 By Type - Global RNA-based Biopharmaceuticals Sales, 2022-2027
4.3.3 By Type - Global RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
4.4 By Type - Global RNA-based Biopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA-based Biopharmaceuticals Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Diabetes
5.1.4 Tuberculosis
5.1.5 Cardiovascular Diseases
5.1.6 Others
5.2 By Application - Global RNA-based Biopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global RNA-based Biopharmaceuticals Revenue, 2016-2021
5.2.2 By Application - Global RNA-based Biopharmaceuticals Revenue, 2022-2027
5.2.3 By Application - Global RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
5.3 By Application - Global RNA-based Biopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global RNA-based Biopharmaceuticals Sales, 2016-2021
5.3.2 By Application - Global RNA-based Biopharmaceuticals Sales, 2022-2027
5.3.3 By Application - Global RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
5.4 By Application - Global RNA-based Biopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global RNA-based Biopharmaceuticals Market Size, 2021 & 2027
6.2 By Region - Global RNA-based Biopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global RNA-based Biopharmaceuticals Revenue, 2016-2021
6.2.2 By Region - Global RNA-based Biopharmaceuticals Revenue, 2022-2027
6.2.3 By Region - Global RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
6.3 By Region - Global RNA-based Biopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global RNA-based Biopharmaceuticals Sales, 2016-2021
6.3.2 By Region - Global RNA-based Biopharmaceuticals Sales, 2022-2027
6.3.3 By Region - Global RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America RNA-based Biopharmaceuticals Revenue, 2016-2027
6.4.2 By Country - North America RNA-based Biopharmaceuticals Sales, 2016-2027
6.4.3 US RNA-based Biopharmaceuticals Market Size, 2016-2027
6.4.4 Canada RNA-based Biopharmaceuticals Market Size, 2016-2027
6.4.5 Mexico RNA-based Biopharmaceuticals Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe RNA-based Biopharmaceuticals Revenue, 2016-2027
6.5.2 By Country - Europe RNA-based Biopharmaceuticals Sales, 2016-2027
6.5.3 Germany RNA-based Biopharmaceuticals Market Size, 2016-2027
6.5.4 France RNA-based Biopharmaceuticals Market Size, 2016-2027
6.5.5 U.K. RNA-based Biopharmaceuticals Market Size, 2016-2027
6.5.6 Italy RNA-based Biopharmaceuticals Market Size, 2016-2027
6.5.7 Russia RNA-based Biopharmaceuticals Market Size, 2016-2027
6.5.8 Nordic Countries RNA-based Biopharmaceuticals Market Size, 2016-2027
6.5.9 Benelux RNA-based Biopharmaceuticals Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia RNA-based Biopharmaceuticals Revenue, 2016-2027
6.6.2 By Region - Asia RNA-based Biopharmaceuticals Sales, 2016-2027
6.6.3 China RNA-based Biopharmaceuticals Market Size, 2016-2027
6.6.4 Japan RNA-based Biopharmaceuticals Market Size, 2016-2027
6.6.5 South Korea RNA-based Biopharmaceuticals Market Size, 2016-2027
6.6.6 Southeast Asia RNA-based Biopharmaceuticals Market Size, 2016-2027
6.6.7 India RNA-based Biopharmaceuticals Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America RNA-based Biopharmaceuticals Revenue, 2016-2027
6.7.2 By Country - South America RNA-based Biopharmaceuticals Sales, 2016-2027
6.7.3 Brazil RNA-based Biopharmaceuticals Market Size, 2016-2027
6.7.4 Argentina RNA-based Biopharmaceuticals Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales, 2016-2027
6.8.3 Turkey RNA-based Biopharmaceuticals Market Size, 2016-2027
6.8.4 Israel RNA-based Biopharmaceuticals Market Size, 2016-2027
6.8.5 Saudi Arabia RNA-based Biopharmaceuticals Market Size, 2016-2027
6.8.6 UAE RNA-based Biopharmaceuticals Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer RNA-based Biopharmaceuticals Major Product Offerings
7.1.4 Pfizer RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche RNA-based Biopharmaceuticals Major Product Offerings
7.2.4 Roche RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.2.5 Roche Key News
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Corporate Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Major Product Offerings
7.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.3.5 Sanofi-Aventis Key News
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Corporate Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Major Product Offerings
7.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.4.5 Abbott Laboratories Key News
7.5 Arrowhead Pharmaceuticals
7.5.1 Arrowhead Pharmaceuticals Corporate Summary
7.5.2 Arrowhead Pharmaceuticals Business Overview
7.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Major Product Offerings
7.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.5.5 Arrowhead Pharmaceuticals Key News
7.6 Benitec Biopharma
7.6.1 Benitec Biopharma Corporate Summary
7.6.2 Benitec Biopharma Business Overview
7.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Major Product Offerings
7.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.6.5 Benitec Biopharma Key News
7.7 Calimmune Inc
7.7.1 Calimmune Inc Corporate Summary
7.7.2 Calimmune Inc Business Overview
7.7.3 Calimmune Inc RNA-based Biopharmaceuticals Major Product Offerings
7.4.4 Calimmune Inc RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.7.5 Calimmune Inc Key News
7.8 Dicerna
7.8.1 Dicerna Corporate Summary
7.8.2 Dicerna Business Overview
7.8.3 Dicerna RNA-based Biopharmaceuticals Major Product Offerings
7.8.4 Dicerna RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.8.5 Dicerna Key News
7.9 Gradalis
7.9.1 Gradalis Corporate Summary
7.9.2 Gradalis Business Overview
7.9.3 Gradalis RNA-based Biopharmaceuticals Major Product Offerings
7.9.4 Gradalis RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.9.5 Gradalis Key News
7.10 Quark
7.10.1 Quark Corporate Summary
7.10.2 Quark Business Overview
7.10.3 Quark RNA-based Biopharmaceuticals Major Product Offerings
7.10.4 Quark RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.10.5 Quark Key News
7.11 RXi
7.11.1 RXi Corporate Summary
7.11.2 RXi RNA-based Biopharmaceuticals Business Overview
7.11.3 RXi RNA-based Biopharmaceuticals Major Product Offerings
7.11.4 RXi RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.11.5 RXi Key News
7.12 Senesco
7.12.1 Senesco Corporate Summary
7.12.2 Senesco RNA-based Biopharmaceuticals Business Overview
7.12.3 Senesco RNA-based Biopharmaceuticals Major Product Offerings
7.12.4 Senesco RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.12.5 Senesco Key News
7.13 Silence Therapeutics
7.13.1 Silence Therapeutics Corporate Summary
7.13.2 Silence Therapeutics RNA-based Biopharmaceuticals Business Overview
7.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Major Product Offerings
7.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.13.5 Silence Therapeutics Key News
7.14 Silenseed
7.14.1 Silenseed Corporate Summary
7.14.2 Silenseed Business Overview
7.14.3 Silenseed RNA-based Biopharmaceuticals Major Product Offerings
7.14.4 Silenseed RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.14.5 Silenseed Key News
7.15 Tekmira
7.15.1 Tekmira Corporate Summary
7.15.2 Tekmira Business Overview
7.15.3 Tekmira RNA-based Biopharmaceuticals Major Product Offerings
7.15.4 Tekmira RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.15.5 Tekmira Key News
7.16 Alnylam Pharmaceuticals
7.16.1 Alnylam Pharmaceuticals Corporate Summary
7.16.2 Alnylam Pharmaceuticals Business Overview
7.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Major Product Offerings
7.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales and Revenue in Global (2016-2021)
7.16.5 Alnylam Pharmaceuticals Key News
8 Global RNA-based Biopharmaceuticals Production Capacity, Analysis
8.1 Global RNA-based Biopharmaceuticals Production Capacity, 2016-2027
8.2 RNA-based Biopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global RNA-based Biopharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RNA-based Biopharmaceuticals Supply Chain Analysis
10.1 RNA-based Biopharmaceuticals Industry Value Chain
10.2 RNA-based Biopharmaceuticals Upstream Market
10.3 RNA-based Biopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 RNA-based Biopharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of RNA-based Biopharmaceuticals in Global Market
Table 2. Top RNA-based Biopharmaceuticals Players in Global Market, Ranking by Revenue (2019)
Table 3. Global RNA-based Biopharmaceuticals Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global RNA-based Biopharmaceuticals Revenue Share by Companies, 2016-2021
Table 5. Global RNA-based Biopharmaceuticals Sales by Companies, (K Units), 2016-2021
Table 6. Global RNA-based Biopharmaceuticals Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers RNA-based Biopharmaceuticals Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers RNA-based Biopharmaceuticals Product Type
Table 9. List of Global Tier 1 RNA-based Biopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA-based Biopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global RNA-based Biopharmaceuticals Sales (K Units), 2016-2021
Table 15. By Type - Global RNA-based Biopharmaceuticals Sales (K Units), 2022-2027
Table 16. By Application - Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global RNA-based Biopharmaceuticals Sales (K Units), 2016-2021
Table 20. By Application - Global RNA-based Biopharmaceuticals Sales (K Units), 2022-2027
Table 21. By Region - Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global RNA-based Biopharmaceuticals Sales (K Units), 2016-2021
Table 25. By Region - Global RNA-based Biopharmaceuticals Sales (K Units), 2022-2027
Table 26. By Country - North America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America RNA-based Biopharmaceuticals Sales, (K Units), 2016-2021
Table 29. By Country - North America RNA-based Biopharmaceuticals Sales, (K Units), 2022-2027
Table 30. By Country - Europe RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe RNA-based Biopharmaceuticals Sales, (K Units), 2016-2021
Table 33. By Country - Europe RNA-based Biopharmaceuticals Sales, (K Units), 2022-2027
Table 34. By Region - Asia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia RNA-based Biopharmaceuticals Sales, (K Units), 2016-2021
Table 37. By Region - Asia RNA-based Biopharmaceuticals Sales, (K Units), 2022-2027
Table 38. By Country - South America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America RNA-based Biopharmaceuticals Sales, (K Units), 2016-2021
Table 41. By Country - South America RNA-based Biopharmaceuticals Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales, (K Units), 2022-2027
Table 46. Pfizer Corporate Summary
Table 47. Pfizer RNA-based Biopharmaceuticals Product Offerings
Table 48. Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Roche Corporate Summary
Table 50. Roche RNA-based Biopharmaceuticals Product Offerings
Table 51. Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Sanofi-Aventis Corporate Summary
Table 53. Sanofi-Aventis RNA-based Biopharmaceuticals Product Offerings
Table 54. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Abbott Laboratories Corporate Summary
Table 56. Abbott Laboratories RNA-based Biopharmaceuticals Product Offerings
Table 57. Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Arrowhead Pharmaceuticals Corporate Summary
Table 59. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Offerings
Table 60. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Benitec Biopharma Corporate Summary
Table 62. Benitec Biopharma RNA-based Biopharmaceuticals Product Offerings
Table 63. Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Calimmune Inc Corporate Summary
Table 65. Calimmune Inc RNA-based Biopharmaceuticals Product Offerings
Table 66. Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Dicerna Corporate Summary
Table 68. Dicerna RNA-based Biopharmaceuticals Product Offerings
Table 69. Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Gradalis Corporate Summary
Table 71. Gradalis RNA-based Biopharmaceuticals Product Offerings
Table 72. Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Quark Corporate Summary
Table 74. Quark RNA-based Biopharmaceuticals Product Offerings
Table 75. Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. RXi Corporate Summary
Table 77. RXi RNA-based Biopharmaceuticals Product Offerings
Table 78. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Senesco Corporate Summary
Table 80. Senesco RNA-based Biopharmaceuticals Product Offerings
Table 81. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 82. Silence Therapeutics Corporate Summary
Table 83. Silence Therapeutics RNA-based Biopharmaceuticals Product Offerings
Table 84. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 85. Silenseed Corporate Summary
Table 86. Silenseed RNA-based Biopharmaceuticals Product Offerings
Table 87. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 88. Tekmira Corporate Summary
Table 89. Tekmira RNA-based Biopharmaceuticals Product Offerings
Table 90. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 91. Alnylam Pharmaceuticals Corporate Summary
Table 92. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Offerings
Table 93. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 94. RNA-based Biopharmaceuticals Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 95. Global RNA-based Biopharmaceuticals Capacity Market Share of Key Manufacturers, 2019-2021
Table 96. Global RNA-based Biopharmaceuticals Production by Region, 2016-2021 (K Units)
Table 97. Global RNA-based Biopharmaceuticals Production by Region, 2022-2027 (K Units)
Table 98. RNA-based Biopharmaceuticals Market Opportunities & Trends in Global Market
Table 99. RNA-based Biopharmaceuticals Market Drivers in Global Market
Table 100. RNA-based Biopharmaceuticals Market Restraints in Global Market
Table 101. RNA-based Biopharmaceuticals Raw Materials
Table 102. RNA-based Biopharmaceuticals Raw Materials Suppliers in Global Market
Table 103. Typical RNA-based Biopharmaceuticals Downstream
Table 104. RNA-based Biopharmaceuticals Downstream Clients in Global Market
Table 105. RNA-based Biopharmaceuticals Distributors and Sales Agents in Global Market
List of Figures
Figure 1. RNA-based Biopharmaceuticals Segment by Type
Figure 2. RNA-based Biopharmaceuticals Segment by Application
Figure 3. Global RNA-based Biopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global RNA-based Biopharmaceuticals Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global RNA-based Biopharmaceuticals Revenue, 2016-2027 (US$, Mn)
Figure 7. RNA-based Biopharmaceuticals Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by RNA-based Biopharmaceuticals Revenue in 2020
Figure 9. By Type - Global RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
Figure 10. By Type - Global RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 11. By Type - Global RNA-based Biopharmaceuticals Price (USD/Unit), 2016-2027
Figure 12. By Application - Global RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
Figure 13. By Application - Global RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 14. By Application - Global RNA-based Biopharmaceuticals Price (USD/Unit), 2016-2027
Figure 15. By Region - Global RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
Figure 16. By Region - Global RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 17. By Country - North America RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 18. By Country - North America RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
Figure 19. US RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 20. Canada RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 23. By Country - Europe RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
Figure 24. Germany RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 25. France RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 27. Italy RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 28. Russia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 32. By Region - Asia RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
Figure 33. China RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 34. Japan RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 37. India RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 39. By Country - South America RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
Figure 40. Brazil RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales Market Share, 2016-2027
Figure 44. Turkey RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 45. Israel RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 47. UAE RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 48. Global RNA-based Biopharmaceuticals Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production RNA-based Biopharmaceuticals by Region, 2020 VS 2027
Figure 50. RNA-based Biopharmaceuticals Industry Value Chain
Figure 51. Marketing Channels

Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals